Abstract
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia seen in clinical practice, which places affected patients at an increased risk of mortality, heart failure and thromboembolic events [1,2]. It is a major global burden on the health care system with evidence suggesting an increasing incidence and prevalence [3–5]. A systematic review of world-wide population-based studies (n=184) has revealed that the age-adjusted prevalence and incidence rates of AF have increased in 2010 compared to 1990 [5].
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
